Available Online: 10 May 2026
The Mirage of Miracle Cures: Hydroxychloroquine and Ivermectin in COVID-19
Volume 1
The global coronavirus disease 2019 (COVID-19) pandemic created unprecedented urgency for effective therapeutic interventions. During the early phase of the pandemic, when specific antivirals and vaccines were unavailable, hydroxychloroquine (HCQ) and ivermectin (IVM) emerged as widely promoted therapeutic candidates due to their reported in vitro antiviral activity, proposed mechanisms of action, and anecdotal clinical observations. Both drugs were rapidly incorporated into clinical practice and national treatment policies despite substantial pharmacological..